Categories: AnalyticsITLabTechnology
Simplicity, Accuracy, Efficiency in DNA tests for cancer patients. Foresee Genomics is developing an innovative testing kit for identifying multiple cancer genomic markers.
Investors 1
Funding Rounds 1
Date | Series | Amount | Investors |
29.01.2025 | - | $1.3M | - |
Mentions in press and media 4
Date | Title | Description |
30.01.2025 | Foresee Genomics Secures $1.3M to Revolutionize Genomic Testing for Smaller Labs | In the ever-evolving landscape of healthcare, precision medicine stands as a beacon of hope. Yet, access to advanced genomic testing often feels like a distant dream for smaller laboratories. Enter Foresee Genomics, a San Francisco-based co... |
29.01.2025 | Foresee Genomics Raises $1.3M in SAFE Financing | Margalit Tocher, CEO of Foresee Genomics
Foresee Genomics, a San Francisco, CA-based next generation sequencing (NGS) solutions company focused on the small and medium-sized laboratory market, raised $1.3M in SAFE (Simple Agreement for Futu... |
28.01.2025 | Foresee Genomics Raises $1.3M in SAFE Financing to Transform Next-Generation Sequencing (NGS) for Small and Medium-Sized Labs | Margalit Tocher, CEO of Foresee Genomics
Funding to Support U.S. Market Launch in 2025 of Fast, Affordable, High-Precision NGS Solutions to Bring Precision Medicine Closer to Every Patient
SAN FRANCISCO, Jan. 28, 2025 /PRNewswire-PRWeb/ -- ... |
- | Foresee Genomics | “Simplicity, Accuracy, Efficiency in DNA tests for cancer patients. Foresee Genomics is developing an innovative testing kit for identifying multiple cancer genomic markers.” |
Reviews 0